D. Walke
Investor Relations Contact bei IONIS PHARMACEUTICALS, INC.
Profil
D.
Wade Walke is the founder of Ionis Pharmaceuticals, Inc. founded in 2012, where he held the title of VP-Corporate Communications & Investor Relations from 2012 to 2018.
Currently, he holds the position of Senior Vice President-Investor Relations at Ionis Pharmaceuticals, Inc. since 2023 and Vice President-Investor Relations at 23andMe, Inc. since 2021.
Previously, he worked as Senior Director-Investor & Media Relations Contact at Lexicon Pharmaceuticals, Inc. from 2011 to 2012 and as Vice President-Investor Relations at 23andMe Holding Co. from 2021 to 2022.
Dr. Walke completed his undergraduate degree at Brigham Young University and his graduate and doctorate degrees at the University of Michigan.
Aktive Positionen von D. Walke
| Unternehmen | Position | Beginn |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Investor Relations Contact | 01.01.2023 |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Investor Relations Contact | 01.06.2021 |
Ehemalige bekannte Positionen von D. Walke
| Unternehmen | Position | Ende |
|---|---|---|
| 23ANDME HOLDING CO. | Investor Relations Contact | 01.06.2022 |
| IONIS PHARMACEUTICALS, INC. | Founder | 01.07.2018 |
| LEXICON PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Ausbildung von D. Walke
| Brigham Young University | Undergraduate Degree |
| University of Michigan | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| 23ANDME HOLDING CO. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
